Gene Therapy and Gene Editing

Gene therapy and gene editing represent transformative approaches in the treatment of hematologic disorders by directly targeting the underlying genetic defects. These strategies involve the introduction, correction, or modification of genetic material within hematopoietic stem or progenitor cells to restore normal blood cell function. Gene therapy has shown significant success in inherited blood disorders by enabling long-term disease correction following a single therapeutic intervention. Gene editing technologies allow precise modification of disease-causing mutations, offering the potential for curative treatment without the need for lifelong therapy. Clinical application requires careful consideration of safety, efficacy, and long-term outcomes. Advances in delivery systems, conditioning regimens, and manufacturing processes have improved therapeutic feasibility and patient access. Ongoing research aims to expand indications, minimize off-target effects, and optimize durability of gene correction. Gene therapy and gene editing are redefining the future of hematology by shifting treatment paradigms from symptom management to genetic cure.